Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ventana and Barco Alliance to Revolutionize Digital Pathology Viewing Experience

By LabMedica International staff writers
Posted on 14 Jun 2013
Ventana Medical Systems, Inc. More...
(VMSI; Tucson, AZ, USA), member of the Roche Group, has announced the signing of a worldwide agreement with healthcare imaging expert Barco, Inc. (Kortrijk Belgium) to provide Barco's leading diagnostic and clinical review display systems for use with Ventana’s Virtuoso image and workflow management system, offering a turnkey solution that provides consistent whole slide image viewing with efficiency.

"This agreement represents a fusion of digital pathology visualization technologies from two of the industry's most innovative healthcare leaders," said Steve Burnell, PhD, digital pathology and workflow lifecycle leader at VMSI; "The Ventana integrated digital pathology solution, now including Barco's products, will appeal to the most discerning practitioners."

The advantages of medical grade displays over commercial off-the-shelf monitors include enhanced contrast; color accuracy and sharpness; prolonged image stability over time; and the ability to calibrate the screen for optimal viewing. Barco's Coronis Fusion 4MP DL diagnostic color display and MDRC-2124 wide-screen clinical monitor offer these capabilities and more for precise, high confidence viewing. Barco's system supports effortless and precise panning and zooming on whole slide images. Moreover, the display system includes Barco's MediCal Awe, an automated, real-time calibration system that provides high image quality and consistency across the screen for the life of the display.

Ventana’s Virtuoso is a comprehensive, web-based software application. From initial slide scanning to complete reporting, the Virtuoso software supports multiple users, enabling remote viewing of slide images, online collaboration sessions with other pathologists, and slide sharing of images. Its intuitive user interfaces are customized for the workflow of pathologists, histotechnologists, lab administrators, and clinicians, enhancing efficiencies throughout the process.

"We are delighted to forge this exciting alliance with Ventana as we solidify our ongoing commitment to the digital pathology market," said Mike Sklar, vice president sales, healthcare, at Barco, North America; "Ventana offers all the ingredients for a successful partnership: in-depth market knowledge, a passion for technology excellence, and unwavering dedication to customer needs—all of the tenets that Barco upholds."

Related Links:
Ventana Medical Systems
Medical Imaging Systems at Barco, Inc.


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.